MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy
BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.
It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.
Vous pourriez aussi aimer
À la hausse
Dernières actus crypto
Coinbase pour inclure HBAR, MANTLE dans l'index COIN50 pour T4
Lors d'un test de simulation Anthropic, AI Agents a découvert une vulnérabilité de contrat intelligent de 4,6 millions de dollars.
Réunions futures de la Fed Risque de voir augmenter les désaccords alimentant la volatilité du marché
Tom Lee: Le rapport risque-rendement des CTB et des EPF devient très attractif
Coinbase est maintenant en ligne avec Rayls (RLS) spot trading
Assistance client:@weikecs
Collaborations commerciales:@weikecs
Trading quantitatif/Market makers:[email protected]
Programme VIP:[email protected]